1-IODOADAMANTANE

CAS No. 768-93-4

1-IODOADAMANTANE( —— )

Catalog No. M19094 CAS No. 768-93-4

1-Iodoadamantane is employed in the free-radical carbonylation reactions with alkenes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 29 In Stock
10MG 32 In Stock
25MG 51 In Stock
50MG 72 In Stock
100MG 105 In Stock
200MG Get Quote In Stock
500MG 261 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    1-IODOADAMANTANE
  • Note
    Research use only, not for human use.
  • Brief Description
    1-Iodoadamantane is employed in the free-radical carbonylation reactions with alkenes.
  • Description
    1-Iodoadamantane is employed in the free-radical carbonylation reactions with alkenes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    768-93-4
  • Formula Weight
    262.13
  • Molecular Formula
    C10H15I
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    IC12CC3CC(CC(C3)C1)C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 6''-O-Malonylgenisti...

    6''-O-Malonylgenistin possesses a hepatoprotective activity.The isoflavone concentration in soybean samples was analyzed on a C 18 reverse-phase column using a two-step gradient solvent system.

  • Z16078526

    Z16078526 enhances thermogenesis in mice by inducing endogenous Ucp1 expression, promoting p38 MAPK phosphorylation, and stimulating lipolysis in primary mouse brown adipocytes.

  • Suritozole

    Suritozole is a negative modulator at the gamma-aminobutyric acidA (GABAA) receptorSuritozole is a negative modulator at the gamma-aminobutyric acidA (GABAA) receptor that enhances cholinergic function, in attenuating spatial memory deficits after traumatic brain injury in the rat.